Targeting the adaptive molecular landscape of castration‐resistant prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|7|878-894

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.7, 2015-07, pp. : 878-894

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recepteur d'origine nantais (RON), more than a kinase: Role in castrate‐resistant prostate cancer

By  

Molecular Carcinogenesis, Vol. 54, Iss. 10, 2015-10 ,pp. : 937-946

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recepteur d'origine nantais (RON), more than a kinase: Role in castrate‐resistant prostate cancer

By  

Molecular Carcinogenesis, Vol. 899-1987, Iss. 10, 2015-10 ,pp. : 937-946

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3‐kinase‐mediated Akt signaling

By  

Molecular Carcinogenesis, Vol. 54, Iss. 9, 2015-09 ,pp. : 751-760

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules

By  

Molecular Carcinogenesis, Vol. 54, Iss. 7, 2015-07 ,pp. : 554-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Silibinin prevents prostate cancer cell‐mediated differentiation of naïve fibroblasts into cancer‐associated fibroblast phenotype by targeting TGF β2

By  

Molecular Carcinogenesis, Vol. 54, Iss. 9, 2015-09 ,pp. : 730-741

John Wiley & Sons Inc

Access to resources Recommend Favorite